Core Insights - Dolby Laboratories reported 357millioninrevenueforthequarterendedDecember2024,markingayear−over−yearincreaseof13.1346.37 million by 3.07% [1] - The company achieved an EPS of 1.14,upfrom1.01 a year ago, with a surprise of 6.54% compared to the consensus estimate of 1.07[1]RevenueBreakdown−RevenuefromProductsandServiceswas26.52 million, surpassing the three-analyst average estimate of 25.24million,reflectingayear−over−yearincreaseof21.6330.48 million, exceeding the average estimate of 321.12million,andshowingayear−over−yeargrowthof12.5309.37 million, compared to the average estimate of 301.40million[4]−GrossMarginforProductsandServiceswas6.86 million, significantly higher than the average estimate of $3.83 million [4] Stock Performance - Shares of Dolby Laboratories have returned +3.2% over the past month, outperforming the Zacks S&P 500 composite's +1.2% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]